Peripheral blood lymphocytes in sarcoidosis

Area of Science:

• Immunology
• Cell Biology
• Medical Research

Background:

• Sarcoidosis commonly presents with altered peripheral blood lymphocyte subpopulations.
• A decrease in thymus-derived lymphocytes (T cells) is frequently observed, while Bursa-derived lymphocytes (B cells) remain typically normal.
• The observed T cell lymphopenia may represent a reversible suppression of receptor function.

Purpose of the Study:

• To investigate the specific alterations in lymphocyte subpopulations in sarcoidosis patients.
• To identify and characterize inhibitory factors present in sarcoidosis serum.
• To explore the relationship between these factors and T suppressor cell activity.

Main Methods:

• Analysis of peripheral venous blood lymphocyte subpopulations.
• In vitro treatment of lymphocytes with Levamisole to assess receptor function.
• Characterization of low molecular weight inhibitory fractions in patient serum.
• Assessment of immune complexes and their correlation with T suppressor cell activation.

Main Results:

• Patients with sarcoidosis exhibit significantly lower T cell counts.
• In vitro Levamisole treatment normalized T cell numbers, suggesting a reversible suppression mechanism.
• Activated T suppressor cells (T gamma) were identified in the peripheral blood of sarcoidosis patients.
• Two inhibitory serum fractions were found: a low molecular weight inhibitor and an immune complex capable of activating T suppressor cells.

Conclusions:

• Sarcoidosis is associated with a distinct pattern of lymphocyte changes, including T cell reduction and T suppressor cell activation.
• Serum from sarcoidosis patients contains inhibitory factors that impact T cell function and promote suppressor cell activity.
• These findings provide insights into the immunopathogenesis of sarcoidosis and potential therapeutic targets.